WALTHAM, Mass., Aug. 1, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that it will present at the upcoming Leerink Swann Life Science Tools & Diagnostics Roundtable on Wednesday, August 3, 2011 at 8:20 a.m. Eastern Time. Pieter Muntendam, MD, President and CEO of the Company, will participate in a roundtable discussion entitled “Diagnostics: Existing and Emerging Opportunities.” He will then present an overview of BG Medicine at 10:50 a.m. Eastern Time. The corporate presentation will be available to the public through a webcast accessible by visiting: http://wsw.com/webcast/leerink22/bgmd/ or the “Investors” section of the Company’s website at www.bg-medicine.com. Replays will be available for 30 days after the presentation.
